MATINAS BIOPHARMA HOLDINGS, INC. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $12.77 million as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Notes › Investments › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2024-03-27
- 2023-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $12.77M.
- 2023-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $19.12M.
- 2022-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $21.93M.
- 2022-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $21.88M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2023-06-30 | $12.77M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $19.12M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $21.93M 10-K · filed 2024-03-27 |
| 2022-09-30 | $21.88M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $28.10M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $24.54M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $28.59M 10-K · filed 2023-03-15 |
| 2021-09-30 | $28.91M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $29.49M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $37.28M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $46.25M 10-K/A · filed 2022-03-11 |
| 2020-09-30 | $55.72K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $53.05K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $61.09K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $5.61M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |